TSE:MFC

Manulife Financial (MFC.TO)

57.19
+0.15 (0.26%)
as of Jun 26, 2026, 8:00:00 pm Market Open.
1634 watching
0
Investor Insights
star iconJun 27, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has received mixed reviews from experts, highlighting its strengths in capital management, particularly in Asia and wealth management. Several analysts view it as a reliable income stock, benefiting from a decent dividend yield, yet caution against its growth potential compared to Canadian banks. The company has faced short-term challenges, including mixed results from its alternative portfolio and limited growth in its U.S. operations, which has sparked some concerns. Analysts suggest waiting for opportunities to buy during pullbacks, given its valuation relative to major financials, alongside the potential for increased profitability stemming from rising interest rates. Overall, while MFC is generally recognized for its stability and improvements in earnings quality, it struggles to capture investor attention amidst recent market shifts.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
SLF-T
PAST TOP PICK

(Top Pick Oct 28/11, Up 22.43%)

PARTIAL BUY

Preeminent insurance company both here and in the US. Has been having a tough time because of risks taken to increase earnings. They have been in a retrench process and until the process is completed we don’t know what the core earning power really is. Until we know that, it is difficult to put a valuation on it. However, it has been trading at or below Book for quite a while so this is a good place to start. Doesn’t see a lot of upside in the short term unless interest rates move sustainably higher or until they can show core earnings are a lot higher.

COMMENT

Won’t get back to the $20 level again for a while. In the short term, he would be looking for a $14 target. If it gets down to the $10 level, that is probably a fantastic buying opportunity if the market starts to gain some strength.

COMMENT

Low interest rates are a real penalty and they suffer when equity markets do not do well. This is really a leveraged play on the performance of the capital markets. However, their underlying sales, particularly outside of North America, are phenomenal and growth prospects are exceedingly good. Working their way through the sins of the past and the current problems. Likes the story longer-term and is on his Watch List. He will be a buyer at $10.

PAST TOP PICK

(Top Pick Oct 14/11, Down 4.73%) Fundamentals look good, technicals look good.

HOLD

Don't hold more than 5% of your portfolio.

HOLD

Doesn’t see this breaking out of the doldrums anytime soon. Had talked about selling his holdings, but given the fact that the markets may pleasantly surprise next year with housing continuing and Europe possibly making a comeback, he has decided to Hold.

DON'T BUY

Manulife (MFC-T) or Power Financial (PWF-T)? Big driver for these are the markets. He is cautiously optimistic and feels that in the short run, markets are okay. Low interest rates are also challenging for lifecos. Asian growth is attractive for Manulife but Asia is having some difficulties right now. Feels there are better sectors to focus on for either one.

COMMENT

Make money, but not as much as they used to. People want them to make a lot more money but it is just not possible when interest rates are so low in the insurance business. It is very hard for them to re-price their policies aggressively. Balance sheets for insurance companies are heavily weighted to interest rates. He has a very small position.

TOP PICK

Still suffering from its financial crisis hangover but that is gradually working its way through the system. 2012 was this company’s return to real profitability. Hedged a lot of their exposure to equity markets. Low interest rates are hurting, but they are dealing with it. Expect they will return to $1.20 earnings range next year, which makes it a 10X earnings stock with a 4.5% dividend yield. Adequate capital ratios. Great growth in Asia, Japan, China and Indonesia.

BUY ON WEAKNESS

(Market Call Minute.) No problem with sales. They are selling stuff like hotcakes. Loves the Asian experience. You have a capital markets and interest-rate problem. Would look at it at $10.

WEAK BUY

(Market Call Minute.) Cheap, but there is the overhang and concern of low interest-rate impact on earnings. Analysts are very bullish on earnings next year. If they are right, then the stock is cheap.

WATCH

Very interestingly positioned. 2012 earnings have come out to about $.65 a share but this includes a lot of haircuts the company is taking in its balance sheet on account of regulatory issues regarding its variable annuity stream. Understands they could do about $1.50 next year so there could be upside to the name. Has a good presence in Asia. If you are looking at it from a tax loss perspective in December with a healthy dividend, it could be a good name.

COMMENT

She has this as a candidate for sale if she finds something more attractive. At this level, there is probably support for book value. Company is being influenced by none controllable events such as interest rates and general market sensitivity. Could be a sale for tax loss selling reasons for her.

HOLD

A good Hold for 3 years or should they Sell? At the current levels, the valuation is quite good but you have to have a 2-3 year time horizon. Low interest rates and mediocre equity markets have not been good for insurance companies.

Showing 1,186 to 1,200 of 2,281 entries